You are here

• Home
• Therapy Areas
• Gastrointestinal

• Maintenance treatment of patients with healed reflux esophagitis, comparing remission rates during 6 months with esomeprazole 20 mg q.d. and lansoprazole 15 mg q.d. - A randomised, double-blind multi-centre study - METROPOLE

Disease

gastrointestinal diseases

Drug Name

Nexium

Generic Name

esomeprazole

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

IIIb

Start Date

May 9, 2000

Study Name

SH-QBE-0067

Study Id

SH-QBE-0067

ClinicalTrials.gov ID

Not Applicable

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jan 18, 1971

• SH-QBE-0067.pdf (79 KB)

Page tools

• Print
• Bookmark this page